Funding the future of retinal health with Eyepoint

Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.

Episode metadata supplied by the publisher feed · Published Sep 3, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Funding the future of retinal health with Eyepoint

0:00 12:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pathfinders in Biopharma?

This episode is 12 minutes long.

When was this Pathfinders in Biopharma episode published?

This episode was published on September 3, 2025.

Can I download this Pathfinders in Biopharma episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!